Novartis to seek speedy approval for Covid drug after positive trials
In lab tests the drug maintained its antiviral activity against all variants of concern
In lab tests the drug maintained its antiviral activity against all variants of concern
Company running coronavirus trial on its hydroxychloroquine drug after Donald Trump intervention
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices